
Auteur E. VICAUT
|
Documents disponibles écrits par cet auteur (3)

A. BATISSE ; S. LEGER ; E. VICAUT ; L. GERBAUD ; S. DJEZZAR | 2021
Dans Public Health (Vol.194, May 2021) Article : PériodiqueObjectives: This descriptive and analytical study investigated the consumption rates of psychoactive substances among individuals aged 18-25 years in France. More specifically, it enabled assessment of the extent of the neuroenhancement (NE) phe[...]
T. PEZEL ; J. G. DILLINGER ; A. TRIMAILLE ; C. DELMAS ; N. PILIERO ; C. BOULETI ; T. POMMIER ; A. EL OUAHIDI ; S. ANDRIEU ; B. LATTUCA ; R. ROSSANALY VASRAM ; D. FARD ; N. NOIRCLERC ; G. BONNET ; M. GORALSKI ; M. ELBAZ ; A. DENEY ; G. SCHURTZ ; C. DOCQ ; F. ROUBILLE ; C. FAUVEL ; T. BOCHATON ; V. ABOYANS ; F. BOCCARA ; E. PUYMIRAT ; A. BATISSE ; G. STEG ; E. VICAUT ; P. HENRY ; ADDICT-ICCU Investigators | 2023
Dans Heart (Vol.109, n°21, November 2023) Article : PériodiqueOBJECTIVE: While recreational drug use is a risk factor for cardiovascular events, its exact prevalence and prognostic impact in patients admitted for these events are not established. We aimed to assess the prevalence of recreational drug use a[...]
B. MEGARBANE ; A. BUISINE ; F. JACOBS ; D. RESIERE ; L. CHEVILLARD ; E. VICAUT ; F. J. BAUD | 2010
Dans Journal of Substance Abuse Treatment (Vol.38, n°4, June 2010) Article : PériodiqueBuprenorphine is a partial opioid agonist with a “ceiling effect” for respiratory depression. Despite this, it has been associated with severe overdoses. Conflicting data exist regarding its response in overdose to naloxone. We compared clinical[...]